By Alex Epstein and Jane Evenson ( July 8, 2024, 4:33 PM BST) -- Since the first monoclonal antibody approval by the U.S. Food and Drug Administration in 1986, which was for Muromonab-CD3, these drugs have become progressively more common, frequently reaching blockbuster status. According to a March report by Statista, 5 out of the 10 top-selling drugs in 2023 were antibodies.[1]...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.